Faes Farma SA risk profile
39 Normal where most of the sector sits
Measured 1 September 2026 from FAE's filed statements. Recomputed nightly.
39 (Normal), driven by Operating pressure at 69, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 34 | Normal | Stable | One-year price volatility — 21.1% |
| Operating pressure | 69 | Stretched | Worsening | Costs outgrowing revenue — +11.1 percentage points |
| Cash conversion | 35 | Normal | Worsening | Cash conversion — 0.99x |
| Leverage and coverage | 22 | Normal | Worsening | Net debt to EBITDA — 2.82x |
| Competitive position | 30 | Normal | Stable | Revenue-growth gap against peers — +1.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.